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We report a new molecular contrast optical coherence tomography (MCOCT) implementation that profiles
the contrast agent distribution in a sample by measuring the agent’s spectral differential absorption. The
method, spectra triangulation MCOCT, can effectively suppress contributions from spectrally dependent scat-
terings from the sample without a priori knowledge of the scattering properties. We demonstrate molecular
imaging with this new MCOCT modality by mapping the distribution of indocyanine green, a FDA-approved
infrared red dye, within a stage 54 Xenopus laevis. © 2004 Optical Society of America
OCIS codes: 110.4500, 170.3880.A hybrid imaging modality that can combine the
contrast-agent specif icity of f luorescence microscopy1
techniques with the higher spatial resolution and
depth penetration of optical coherence tomography2,3
(OCT) will dramatically enhance the capability of clini-
cians and biomedical researchers to track chemical
changes within patients and experimental subjects.
The recognition of this fact has prompted several
research groups to implement various modified OCT
schemes that have the capability to detect specific
contrast agents (chemical4 and otherwise5).
In this Letter we present what is believed to be
the f irst molecular contrast optical coherence tomogra-
phy (MCOCT) implementation, spectral triangulation
MCOCT, that is capable of profiling the distribution of
a FDA-approved dye, indocyanine green (ICG), within
a target sample. Our method opens up the possibility
of performing contrast-based imaging through whole
small animals and potentially extends the imaging ca-
pability of existing clinical procedures that involve the
use of ICG.6
Spectroscopic OCT methods7,8 that yield spectrally
resolved images represent the f irst attempts at
extracting the distribution of absorptive chemical–
biochemical species. However, the lack of compen-
sation for turbidity variation within the samples can
lead to significant artifacts in rendering contrast
distribution images for biological samples. Our
method, spectral triangulation MCOCT, is a sig-
nificant enhancement of spectroscopic OCT in that
it corrects for any significant spectral variation of
the sample’s turbidity up to the f irst order without
a priori knowledge of the variation.
The spectral triangulation MCOCT method is based
on acquiring three consecutive OCT pixels, A-scans, or0146-9592/04/172016-03$15.00/0B-scans at evenly spaced wavelength intervals. One
of the scans is collected at a mean wavelength that
closely matches the absorption maximum wavelength
of the target contrast agent, while the other two
scans are taken at wavelengths above and below
this absorption maximum. By analyzing the three
scans with a triangulation algorithm, we extract an
OCT signal that resolves the depth of the differential
absorption profile of the sample that corresponds
to the cumulative distribution of the contrast agent
within the sample.
Mathematically, the detected OCT signal for a spe-
cific sample depth and center wavelength is given by
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where PRo is the collected reference-arm power, PSo is
the collected signal-arm power if the sample is fully
ref lective, Rl, z is the sample ref lectivity at depth
z, and lc is the OCT coherence length. The additional
exponential term accounts for the loss of collected light
due to absorption [modeled by the absorption coeffi-
cient mal, z0] and scattering [modeled by the scatter-
ing coefficient msl, z0]. We simplify the expression
by restricting our analysis of the OCT images to a spa-
tial resolution that is no less than the coherence length.© 2004 Optical Society of America
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OCT scans at different wavelengths l1, l2, l3:
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where Dmaz0  1/2mal1, z0 1 1/2mal3, z0 2
mal2, z0. The approximation is derived by making
the reasonable assumptions that only the zeroth-order
and the linear terms of the Taylor series spectral
expansions of msl, z0 and Rl, z are significant. If
the wavelength range is chosen to appropriately span
a spectral absorption maximum, we can maximize
the detected contrast, Dmaz0, in the sample. The
ability of this method to eliminate the first-order
spectral variation contribution of the surrounding
turbidity is particularly important, as the contribution
is not negligible and was previously shown to skew
spectroscopic OCT images.7,8
We can further process the image to unwrap the inte-
gration in Eq. (2) and obtain the depth-resolved (rather
than depth-integrated) location of the differential ab-
sorption change:
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In a proof-of-principle demonstration, we chose ICG,
a dye commonly used in clinical hepatic function track-
ing9 and f luorescence angiography,6 as our targeted
contrast agent. This dye has a well-characterized
absorption spectrum that peaks at 790 nm and a
FHWM of 60 nm (see Fig. 1).
The imaging setup employed was a standard Michel-
son interferometer system. A tunable Ti:sapphire
laser with a FHWM linewidth of 11 nm (calculated
coherence length of 25 mm) serves as the OCT light
source. The light was split at a beam splitter. One
part at power PRo was retroref lected by a corner
cube mounted on a scanning galvanometer scanner
and served as a reference light beam. The scanner
created a Doppler frequency upshift of 40 kHz on
the ref lected reference beam. The remainder of the
light, PSo, 100 mW was focused (Newport M-20X
objective) onto a target sample, and the backscattered
light (signal) was recoupled back into the interfer-
ometer. The FWHM of the focal spot on the sample
was 6.9 mm, and the depth of focus was 124 mm. The
combined ref lected reference and backscattered light
was detected, processed by a lock-in amplifier, and
acquired by a computer. The system acquired 2-mm
optical path length A-scans at a rate of approximately
5 Hz. The Ti:sapphire was tuned between each OCT
image acquisition to generate the three OCT image
sets at regular wavelength intervals: 760, 795, and
830 nm.
The sample was a 1-mm-thick capillary f illed with
200-mM concentration of ICG in a scattering medium(0.25% volume concentration suspension of 0.1-mm
microspheres) inserted within a glass cuvette that
contained only the scattering medium. The highly
dispersive medium had a wavelength-dependent scat-
tering coefficient ranging from 0.68 to 1.01 mm21 for
the imaging wavelength range.
Figure 2e shows the averaged A-scans at the three
wavelengths extracted at the location indicated by
the arrow labeled e/f in Fig. 2b. The contrast agent
is not present in the scan region mal, xs  0; the
difference in the three A-scans is due to the spectral
difference in msl, xs. The good match of the two
curves in Fig. 2f, which correspond to the numer-
ator and the denominator of Eq. (2), demonstrates
the strength of the algorithm to correct for most
of the spectral variation in scattering. Figure 2g
shows the corresponding averaged A-scans from a
location that matches the capillary’s position (see
the location indicated by the arrow labeled g/h in
Fig. 1. Absorption spectrum of ICG. The arrows indicate
the center wavelengths at which we acquired our MCOCT
images.
Fig. 2. a, Cross section of the target sample; the arrows
indicate probe light direction, green represents the location
of the ICF and the scattering medium, and the surrounding
gray region represents the scattering medium. b, OCT
image at 795 nm (average of 300 scans); the arrows locate
line traces for Figs. 1(e)–1(h). The imaging focal plane is
near the bottom of the capillary tube. c, Contrast image
created by using the image processing method described in
Eq. (2). d, Unwrapped contrast image based on processing
described in Eq. (3). e and g, OCT A-scans at different
wavelengths (green, 760 nm; red, 795 nm; blue, 830 nm).
f and g, Processed scans corresponding to the numerator
(blue) and the denominator (red) of Eq. (2). The vertical
scales for e–h are normalized to unity.
2018 OPTICS LETTERS / Vol. 29, No. 17 / September 1, 2004Fig. 3. a, Ventral view of a stage 54 Xenopus laevis
tadpole; the red line indicates the location where images
are acquired. b, OCT image of the illuminated regions:
(i) parabranchial cavity, (ii) gill arches, (iii) opercular
field. (c) Spectral triangulation MCOCT contrast image
of the same region.
Fig. 2b). The difference in the processed signal in
Fig. 2h can be completely attributed to the absorptive
contribution of the contrast agent. Figure 2c shows
the processed B-scan plotting the value of Sz. The
presence of the contrast agent within the capillary
and its shadowing effect on light transmitted through
the capillary is clearly evident. By performing the
additional unwrapping processing, we can further
localize the contrast agent’s presence to within
the capillary (see Fig. 2d). The measured ma was
0.19 mm21. The calculated ICG concentration was
70 mM, whereas the actual ICG concentration used
was 200 mM. The discrepancy can be attributed
to the possible adherence of dye molecules to the
microspheres and the subsequent catalytic formation
of multimers, which have different absorption spectra.
To demonstrate contrast-agent detection capability
in an animal model, we injected a mixture of 400-mM
ICG and 0.25% volume concentration 0.1-mm latex
microspheres into the gill arch cavities and the peri-
branchial cavity of a euthanized stage 54 Xenopus
laevis tadpole. B-scans of the animal were acquired
sequentially at three wavelengths (760, 795, and
830 nm) from the location depicted by a red line in
Fig. 3a. A sample size of 30 repeats was acquired
over 1.5 h. The data set was processed, and the
distribution of Sz is shown in Fig. 3b. The localiza-
tion of ICG within the gill arches and peribranchial
cavity is clearly evident in the derived cumulative
ICG distribution image. The expected absence of
ICG from within the gill tissues and beyond the
opercular fold agrees well with the lack of signal in
the associated regions.
The MCOCT image in Fig. 3b is notable for its pene-
tration depth 2 mm and resolution (25 mm axial
and 9 mm lateral). It represents what is to our know-
ledge the f irst demonstration of an OCT-based scheme
to localize and map the distribution of a FDA-approved
dye within a biological target. Further, the light in-
tensity used was well within the ANSI safety limit for
both ocular and skin exposure.10The intrinsic absorption of the biological sample is
ignored in our analysis. This is because of the wave-
length of the scans chosen to optimize the contrast sen-
sitivity of our technique to the applied dye; although it
is plausible, it is unlikely in reality that the spectral
variation of the intrinsic tissue absorption will have a
substantial second-order variation that coincides with
that of the introduced dye within the chosen wave-
length range.
The compact algorithm described represents an
efficient approach for extracting absorptive contrast
distribution from the target. A limitation of this tech-
nique is the long imaging times needed to average away
time variations in the tissue speckle pattern. This
can be overcome by using Fourier-domain OCT tech-
niques,11,12 which can permit the rapid and simultane-
ous acquisition of OCT scans at three different center
wavelengths. The elimination of speckle artifacts and
the dramatic signal-to-noise improvement of Fourier-
domain OCT over conventional OCT by more than
20 dB is predicted to lead to a much shorter acqui-
sition time of 2 s (Ref. 13) and to greater contrast
sensitivity.
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ICG as a MCOCT contrast agent, most notably Hubert
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